Foundry Partners LLC increased its position in shares of Exelon Co. (NYSE:EXC) by 31.1% in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 624,543 shares of the energy giant’s stock after buying an additional 148,215 shares during the period. Exelon accounts for 1.2% of Foundry Partners LLC’s holdings, making the stock its 6th biggest holding. Foundry Partners LLC owned about 0.06% of Exelon worth $29,941,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in EXC. Rockefeller Capital Management L.P. increased its stake in Exelon by 3,771.2% in the first quarter. Rockefeller Capital Management L.P. now owns 30,195 shares of the energy giant’s stock valued at $1,514,000 after purchasing an additional 29,415 shares in the last quarter. Capital Investment Advisors LLC bought a new stake in Exelon in the second quarter valued at $247,000. USS Investment Management Ltd increased its stake in Exelon by 247.6% in the first quarter. USS Investment Management Ltd now owns 878,381 shares of the energy giant’s stock valued at $44,020,000 after purchasing an additional 625,681 shares in the last quarter. Sumitomo Mitsui Trust Holdings Inc. increased its stake in Exelon by 1.7% in the first quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 4,156,262 shares of the energy giant’s stock valued at $208,353,000 after purchasing an additional 70,124 shares in the last quarter. Finally, Occidental Asset Management LLC increased its stake in Exelon by 6.6% in the fourth quarter. Occidental Asset Management LLC now owns 12,381 shares of the energy giant’s stock valued at $558,000 after purchasing an additional 766 shares in the last quarter. 79.67% of the stock is owned by institutional investors and hedge funds.

Exelon stock traded up $0.35 during midday trading on Monday, hitting $46.17. 85,230 shares of the stock were exchanged, compared to its average volume of 5,543,646. Exelon Co. has a 52-week low of $41.65 and a 52-week high of $51.18. The company has a market capitalization of $44.49 billion, a PE ratio of 14.75, a price-to-earnings-growth ratio of 4.08 and a beta of 0.37. The stock’s 50-day simple moving average is $48.92. The company has a quick ratio of 0.89, a current ratio of 1.02 and a debt-to-equity ratio of 0.99.

Exelon (NYSE:EXC) last released its quarterly earnings results on Thursday, May 2nd. The energy giant reported $0.87 earnings per share for the quarter, hitting the consensus estimate of $0.87. Exelon had a net margin of 6.52% and a return on equity of 8.85%. The business had revenue of $9.48 billion for the quarter, compared to analysts’ expectations of $9.10 billion. During the same period in the previous year, the company earned $0.96 earnings per share. The firm’s revenue for the quarter was down 2.2% compared to the same quarter last year. As a group, analysts predict that Exelon Co. will post 3.11 EPS for the current year.

Several research firms have recently commented on EXC. Wells Fargo & Co set a $68.00 target price on shares of Emergent Biosolutions and gave the stock a “hold” rating in a research report on Tuesday, April 2nd. Barclays reissued a “top pick” rating and set a GBX 3,250 ($42.47) target price on shares of in a research report on Wednesday, June 19th. Goldman Sachs Group raised shares of Exelon from a “neutral” rating to a “buy” rating and boosted their target price for the stock from $48.00 to $52.00 in a research report on Thursday, June 6th. ValuEngine raised shares of Worldline from a “hold” rating to a “buy” rating in a research report on Tuesday, July 23rd. Finally, Mizuho decreased their target price on shares of Depomed from $6.00 to $3.00 and set a “neutral” rating for the company in a research report on Thursday, May 16th. Eight analysts have rated the stock with a hold rating and seven have given a buy rating to the company’s stock. Exelon presently has an average rating of “Hold” and a consensus target price of $49.96.

In other Exelon news, EVP Kenneth W. Cornew sold 54,300 shares of the business’s stock in a transaction dated Tuesday, June 18th. The shares were sold at an average price of $49.82, for a total value of $2,705,226.00. Following the transaction, the executive vice president now directly owns 97,813 shares in the company, valued at $4,873,043.66. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, CEO Calvin Butler, Jr. sold 31,000 shares of the business’s stock in a transaction dated Friday, June 28th. The shares were sold at an average price of $47.59, for a total transaction of $1,475,290.00. Following the completion of the transaction, the chief executive officer now owns 40,331 shares in the company, valued at $1,919,352.29. The disclosure for this sale can be found here. 0.27% of the stock is currently owned by insiders.

About Exelon

Exelon Corporation, a utility services holding company, engages in energy generation and delivery businesses in the United States and Canada. It owns nuclear, fossil, wind, hydroelectric, and solar generating facilities. The company also sells electricity to wholesale and retail customers; and sells natural gas, renewable energy, and other energy-related products and services.

Recommended Story: Google Finance Portfolio Tips and Tricks

Institutional Ownership by Quarter for Exelon (NYSE:EXC)

Receive News & Ratings for Exelon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exelon and related companies with MarketBeat.com's FREE daily email newsletter.